A new study found that the weight loss drug Ozempic can help reduce a stroke patient’s risk of a heart attack or death. The ...

Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.

在GLP-1药物的研发和销售大战硝烟滚滚的背后，一场关于药物专利的纷争也在展开。 11月11日，减肥药概念集体上涨。Wind减肥 ...

Results from a late-stage clinical trial are expected in December of this year and, if positive, could reignite Novo shares.

形象意识强的网红和有钱人已经不是唯一的使用者。目前，每八名美国成年人中就有一人在使用司美格鲁肽一类的GLP-1药物。诺和诺德公司生产了司美格鲁肽类药物奥泽米克（用于糖尿病）和韦戈维（用于减肥）。礼来公司则推出了相似的替代品替尔泊肽。

Sahpra warns of falsified diabetes treatments Ozempic and Mounjaro sold online for weight loss, posing health risks.

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

A new study has found that SGLT-2 inhibitor drugs for type 2 diabetes may also reduce the risk of kidney stones and gout. These painful conditions are ...

The analysis used health data from the Rochester Epidemiology Project collected from 2000 to 2022. The first GLP-1 medication was prescribed beginning in 2006, and the authors included cases beginning ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...